May 29, 2026 — GE HealthCare recently announced that its MIM KineticID modeling software1 is now 510(k) pending with the U.S. Food and Drug Administration.
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...
May 29, 2026 — GE HealthCare recently announced that its MIM KineticID modeling software1 is now 510(k) pending with the ...
May 27, 2026 — A large multisite study of older people with cognitive impairment finds that Black and Hispanic people ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
Feb. 19, 2026 — Positrigo, a Swiss based company developing nuclear medical devices to advance functional brain imaging ...
Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...
Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...
Dec.16, 2025 — Three international nuclear medicine organizations — the SNMMI Clinical Trials Network (SNMMI-CTN), the ...
Nov. 18, 2025 — Siemens Healthineers positron emission tomography (PET) radiopharmaceutical companies PETNET Solutions ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
Oct. 22, 2025 — Vistim Labs has announced that its flagship product, Ceregram, is officially ready for launch in ...
Oct. 16, 2025 — A strategic collaboration between UC San Diego Health and GE HealthCare will focus on bringing advanced ...
Sept. 20, 2025 — A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative ...
Sept. 11, 2025 — A new PET tracer can provide insights into how spinal cord injuries affect not only the spinal cord ...
July 22, 2025 — GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device ...
Jun. 24, 2025 — GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) approved an updated label ...
June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a physics ...
May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...
June 02, 2026 